Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

标题
Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 28, Issue 4, Pages 614-619
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2009-10-20
DOI
10.1200/jco.2009.23.6406

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now